CanSino Biologics (6185.HK) Earnings Analysis
CanSino Biologics (6185.HK) next reports earnings on 2026-08-29. Last quarter (2026-03-30) it missed with EPS 0.06041 HKD vs 0.3438 HKD est (-82.4%). It has beaten estimates in 3/5 recent quarters (60%). Trailing P/E 1683.56.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 6185.HK next report earnings?
| Next earnings date | 2026-08-29 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | 0.21B |
6185.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-30 | 0.06041 HKD | 0.3438 HKD | -82.4% | Miss |
| 2025-10-27 | 0.1203 HKD | -0.00507 HKD | +2472.8% | Beat |
| 2025-08-20 | -0.00629 HKD | -0.08785 HKD | +92.8% | Beat |
| 2025-02-27 | -0.63 HKD | -0.24 HKD | -162.5% | Miss |
| 2024-08-29 | -0.22 HKD | -0.37 HKD | +40.5% | Beat |
Beat rate: 3/5 (60%) over reported quarters with consensus data.
6185.HK valuation and analyst view
| Trailing P/E | 1683.56 |
|---|---|
| Trailing EPS | -0.00407 HKD |
| Price / book | 2.52 |
| Dividend yield | 0.00% |
| Market cap | 8.52B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is CanSino Biologics (6185.HK)'s next earnings date?
CanSino Biologics is next scheduled to report on 2026-08-29 and revenue estimate of 0.21B.
Did 6185.HK beat earnings last quarter?
In its 2026-03-30 report, 6185.HK posted EPS of 0.06041 HKD versus a 0.3438 HKD estimate — a miss of 82.4%.
What is 6185.HK's earnings track record?
Over the last 5 reported quarters with consensus data, 6185.HK beat estimates 3 times (60%).
What is 6185.HK's current P/E ratio and EPS?
6185.HK trades at a trailing P/E of 1683.56 on trailing EPS of -0.004072698832868103 HKD.
What do analysts rate 6185.HK?
6185.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.